Background
Air pollution is a major global health concern, with most attention traditionally paid to outdoor pollution, primarily caused by industrial emissions, vehicular traffic, and fossil fuel combustion. However, indoor pollution, or air pollution inside buildings, poses a significant, often underestimated, threat to human health. With people spending approximately 90% of their time indoors, it is essential to understand the link between indoor pollution and respiratory disease. This article explores the sources of indoor pollution, the mechanisms by which these pollutants affect the respiratory tract, and the implications for public health. Indoor pollution is generated by a wide range of sources, many of which are present in our homes, workplaces, and public spaces. Indoor pollutants can be chemical, biological, or physical in nature, and each can have adverse effects on respiratory health.
Chemical pollutants
Indoor chemical pollutants are often produced by building materials, furniture, cleaning products, and everyday activities such as cooking and smoking.
- Volatile Organic Compounds (VOCs): VOCs are a class of chemical pollutants that evaporate easily at room temperature. They are found in paints, solvents, adhesives, cleaners, and personal care products. Common VOCs include benzene, toluene, formaldehyde, and methylene chloride. Exposure to VOCs has been linked to respiratory irritation, asthma, and, in the long term, an increased risk of cancer.
- Carbon Monoxide (CO): Carbon monoxide is a colorless, odorless gas produced by the incomplete combustion of fossil fuels, such as gas, coal, wood, and oil. It can accumulate indoors when heating systems, stoves, or fireplaces are not properly ventilated. Acute exposure to CO can lead to poisoning, with symptoms ranging from headaches and dizziness to severe neurological damage and death.
- Nitrogen Dioxide (NO2): Nitrogen dioxide is another byproduct of combustion and can come from gas stoves, fuel-fired heaters, and vehicles. It can irritate the airways, aggravate asthma, and reduce lung function, especially in children and the elderly.
Biological Pollutants
Biological pollutants include microorganisms and biological substances that can cause allergic reactions and respiratory infections. Mold is a type of fungus that grows in damp, poorly ventilated environments. Mold spores, when inhaled, can cause allergies, asthma, and other respiratory conditions, especially in people with compromised immune systems. Dust mites are small arthropods that live in beds, carpets, and upholstered furniture. Their feces and body parts are potent allergens that can trigger asthma and allergic rhinitis. Pet dander and pollen are other common sources of indoor allergens that can worsen asthma and respiratory allergy symptoms.
Physical Pollutants
Physical pollutants are particles or solid substances that can be suspended in the air and inhaled, causing irritation and damage to the lungs. Particulate matter is a mixture of solid and liquid particles suspended in the air. PM2.5 (particles smaller than 2.5 micrometers in diameter) and PM10 (particles smaller than 10 micrometers in diameter) are particularly dangerous because they can penetrate deep into the lungs and even enter the bloodstream. Indoor sources of PM include tobacco smoke, candles, wood-burning stoves, and gas stoves. Environmental tobacco smoke, also known as secondhand smoke, is a major source of indoor pollution. It contains a complex mix of toxic chemicals, including VOCs, particulate matter, and heavy metals, which can cause respiratory disease, lung cancer, and heart disease.
Mechanisms of action on the respiratory system
Exposure to indoor pollutants can have acute and chronic effects on the respiratory tract, with mechanisms that vary depending on the type and concentration of the pollutant. Many indoor pollutants act as irritants, causing inflammation of the mucous membranes of the respiratory tract. This inflammation can lead to increased mucus production, coughing, wheezing, and difficulty breathing. In susceptible individuals, prolonged exposure can aggravate pre-existing conditions such as asthma and chronic bronchitis. VOCs, tobacco smoke, and particulate matter can stimulate the production of inflammatory cytokines and chemical mediators, which lead to chronic airway inflammation, bronchial wall thickening, and reduced airflow.
Some pollutants, such as nitrogen dioxide and carbon monoxide, can increase bronchial reactivity, making the airways more sensitive to stimuli such as allergens, cold, and viral infections. Indoor pollutants can induce oxidative stress, a process in which reactive oxygen species (ROS) are formed that can damage lung cells and tissue. Oxidative stress caused by exposure to fine particulate matter and nitrogen oxides can lead to direct damage to airway epithelial cells, contributing to loss of function and degeneration of lung tissue. The ROS produced in response can activate inflammatory signaling pathways, further exacerbating lung damage and increasing the risk of chronic respiratory diseases.
Respiratory health impacts
Indoor air pollution has been associated with a variety of respiratory conditions, ranging from mild symptoms to severe and life-threatening illnesses.
Asthma and hay fever
Asthma is a chronic respiratory disease characterized by inflammation of the airways and obstruction of airflow, often triggered by allergens and irritants in the air. Allergic rhinitis, on the other hand, is an inflammation of the nasal mucosa caused by an allergic reaction. Both conditions can be exacerbated by indoor air pollution. Epidemiological studies have shown that children exposed to high levels of indoor pollutants are at greater risk of developing asthma and allergic rhinitis than unexposed children.
Chronic bronchitis and COPD
Chronic bronchitis and Chronic Obstructive Pulmonary Disease (COPD) are respiratory diseases characterized by chronic inflammation of the airways, excessive mucus production, and difficulty breathing. Indoor air pollution is a major risk factor for the development and progression of these conditions. Environmental tobacco smoke is a major cause of chronic bronchitis and COPD. It contributes to chronic inflammation of the airways and destruction of lung tissue. Long-term exposure to fine indoor particulate matter is associated with an accelerated decline in lung function and an increased risk of developing COPD.
Respiratory infections
Indoor air pollution can increase susceptibility to respiratory infections, such as pneumonia and acute bronchitis, especially in children, the elderly, and individuals with compromised immune systems. Mold (especially Aspergillus spp.) and bacteria in indoor environments can cause acute respiratory infections, especially in individuals with weakened immune systems or pre-existing respiratory diseases.
Lung cancer
Indoor air pollution is also associated with an increased risk of lung cancer, particularly among nonsmokers exposed to environmental tobacco smoke or radon. Environmental tobacco smoke is a known cause of lung cancer in nonsmokers. Carcinogens in secondhand smoke can damage the DNA of lung cells, leading to tumor formation. Radon is a naturally occurring radioactive gas that can accumulate in buildings, especially basements and poorly ventilated homes. Exposure to radon is a leading cause of lung cancer in nonsmokers. Not to exclude, finally, that some VOCs and other components in detergents, cleansers and home sprays may contribute to this cancer risk.
Mitigation and Prevention Strategies
To reduce the impact of indoor air pollution on respiratory health, it is essential to adopt mitigation strategies that reduce exposure to indoor pollutants and improve indoor air quality. Adequate ventilation is essential to dilute and remove indoor pollutants. Opening windows, using exhaust fans, and regularly maintaining HVAC (heating, ventilation and air conditioning) systems can help improve indoor air quality.
- Natural Ventilation: Regularly opening windows to let in fresh air can significantly reduce indoor pollutant levels. However, this may be less effective in areas with high outdoor pollution.
- Mechanical Ventilation Systems: Mechanical ventilation with heat recovery (HRV) or energy recovery ventilation (ERV) systems can be used to improve indoor air quality while maintaining the energy efficiency of buildings.
Reducing sources of pollution
Identifying and reducing sources of indoor pollution is a crucial step in preventing respiratory illnesses. Banning smoking in homes and workplaces is one of the most effective measures to reduce indoor pollution and prevent respiratory illnesses. Maintaining indoor humidity between 30% and 50% can prevent mold growth and dust mite proliferation, thus reducing the risks associated with these allergens. Using air quality monitoring devices and air filtration systems can help keep indoor air clean and safe.
Air quality monitoring devices can detect levels of CO2, VOCs, particulate matter and other pollutants, providing real-time data to quickly intervene if safety limits are exceeded. Air purifiers equipped with High-Efficiency Particulate Air (HEPA) filters can remove fine particles and allergens from indoor air, improving air quality and reducing respiratory symptoms. Raising public awareness and implementing appropriate policies are essential to reduce the impact of indoor air pollution on respiratory health, especially in vulnerable populations such as children, the elderly, and individuals with pre-existing respiratory diseases.
- Edited by Dr. Gianfrancesco Cormaci, PhD, specialist in Clinical Biochemistry.
Scientific references
Dam VH, Köhler-Forsberg K et al. Biol Psychiatry. 2024 Aug 22.
Murphy SE et al. Psychol Med. 2021 May; 51(7):1111-1120.
Darcet F, Gardier AM et al. Neurosci Lett. 2016; 616:197-203.
Lucas G, Rymar VV et al. Neuron. 2007 Sep; 55(5):712-25.
US Environmental Protection Agency (EPA). (2019). Indoor air quality (IAQ). US EPA.
World Health Organization (WHO). (2010). WHO guidelines for indoor air quality: selected pollutants. World Health Organization.
Kim KH, Jahan SA et al. (2011). J Hazard Mater. 192(2), 425-431.
Kampa M, Castanas E. (2008). Environ Pollution, 151(2), 362-367.
Jaakkola JJ, Knight, TL. (2008). Environ Health Persp. 116(4), 459.
Fisk WJ, Lei GQ, Mendell MJ. (2007). Indoor Air, 17(4), 284-296.
Naeher LP, Brauer M et al. (2007). Inhalation Toxicol. 19(1), 67-106.
Rehwagen M et al. (2003). Sci Total Environment, 307(1-3), 49-64.
Jones AP. (1999). Atmospheric Environment, 33(28), 4535-4564.